Invention Grant
- Patent Title: Pyrrolidine derivatives acting as CCR3-receptor antagonists
- Patent Title (中): 作为CCR3受体拮抗剂的吡咯烷衍生物
-
Application No.: US10585615Application Date: 2005-01-28
-
Publication No.: US07754758B2Publication Date: 2010-07-13
- Inventor: Gurdip Bhalay , Andrew Dunstan , Angela Glen , Trevor John Howe , Clive McCarthy
- Applicant: Gurdip Bhalay , Andrew Dunstan , Angela Glen , Trevor John Howe , Clive McCarthy
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent John Alexander
- Priority: GB0402101.0 20040130
- International Application: PCT/EP2005/000874 WO 20050128
- International Announcement: WO2005/075420 WO 20050818
- Main IPC: C07D207/12
- IPC: C07D207/12 ; A61K31/40
Abstract:
Compounds of formula I in free or salt form, wherein T, X, Y, U, R1, R2, m, n and p have the meanings as indicated in the specification, are useful for treating conditions mediated by CCR3. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
Public/Granted literature
- US20090306138A1 PYRROLIDINE DERIVATIVES ACTING AS CCR3-RECEPTOR ANTAGONISTS Public/Granted day:2009-12-10
Information query
